Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | 19333636468 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Febuxostat Impurity 4 | C16H16N2O3S | 1335202-59-9 | Details |
| Febuxostat Related Compound A | C16H18N2O4S | 1239233-86-3 | Details |
| Febuxostat Impurity 16 | C12H8N2O3S | 407582-48-3 | Details |
| FeBuxostat Impurity 26 | C14H12N2O3S | 1886961-39-2 | Details |
| Febuxostat Impurity H | C16H17NO5S | 1239233-87-4 | Details |
| Febuxostat Impurity 8 | C16H17NO4S | 144060-62-8 | Details |
| Febuxostat Impurity K | C15H14N2O3S | 144060-52-6 | Details |
| Febuxostat Impurity 58 | C11H9NO3S | 886501-78-6 | Details |
| Febuxostat Impurity 19 | C22H24N2O5S2 | 1330632-47-7 | Details |
| 5-Thiazolecarboxylic acid, 2-[3-carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-, 5-methyl ester | C17H19NO5S | 2476465-39-9 | Details |
| Febuxostat Impurity 14 | C15H16N2OS | 1335202-60-2 | Details |
| 1,4-ANDROSTADIEN-11-BETA-OL-3,17-DIONE | C19H24O3 | 898-84-0 | Details |
| Mometasone Furoate EP Impurity M | C22H29ClO4 | 57780-86-6 | Details |
| Mometasone Furoate Impurity Q | C22H27ClO4 | 83881-08-7 | Details |
| Enzalutamide Impurity 33 | C17H8F6N4S | 1839619-50-9 | Details |
| Methyl 4-bromo-2-fluorobenzoate | C8H6BrFO2 | 179232-29-2 | Details |
| 2-(Methoxy(4-phenoxyphenyl)Methylene)Malononitrile | C17H12N2O2 | 330792-69-3 | Details |
| 5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile | C16H12N4O | 330792-70-6 | Details |
| Enzalutamide Impurity M | C20H13F4N3O3S | 1242137-15-0 | Details |
| Enzalutamide impurity B | C8H7BrFNO | 749927-69-3 | Details |
| N-[3-Fluoro-4-[(MethylaMino)carbonyl]phenyl]-2-Methylalanine | C12H15FN2O3 | 1289942-66-0 | Details |
| Enzalutamide Impurity J | C21H16F4N4O3 | 1242137-18-3 | Details |
| Febuxostat Impurity S | C20H20N2O5S2 | 1330632-48-8 | Details |
| Febuxostat Impurity 5 | C15H17NO3S | 1206550-99-3 | Details |
| ethyl 2-(2-(4-hydroxyphenyl)thiazol-4-yl)acetate | C13H13NO3S | 886503-50-0 | Details |
| Febuxostat Impurity 8 | C13H13NO3S | 161797-99-5 | Details |
| Febuxostat Impurity 59 | C16H16N2O4S | 2418591-42-9 | Details |
| Febuxostat Impurity 13 | C12H16N2OS2 | 1330632-46-6 | Details |
| 2-(2-Methylthiazol-5-yl)acetic acid | C6H7NO2S | 52454-65-6 | Details |
| Febuxostat Impurity 63 | C10H9NOS | 138330-01-5 | Details |
| Febuxostat Impurity Z10 | C11H13NO | 5203-15-6 | Details |
| Celecoxib Impurity A | C17H14F3N3O2S | 170570-01-1 | Details |
| Celecoxib Impurity 3 | C16H12F3N3O2S | 170569-87-6 | Details |
| Celecoxib Impurity F | C17H14F3N3O2S | 170569-99-0 | Details |
| Acotiamide Hydrochloride impurity F | C14H14N2O6S | 185106-01-8 | Details |
| Acotiamide Impurity 10 | C13H12N2O6S | 1809272-85-2 | Details |
| Acotiamide Hydrochloride impurity K | C18H24N4O5S | 701197-05-9 | Details |
| 2-(Hydroxy(4-phenoxyphenyl)methylene)malononitrile | C16H10N2O2 | 330792-68-2 | Details |
| AcotiaMide | C21H30N4O5S | 185106-16-5 | Details |
| 2-Ethyl Milrinone | C13H11N3O | 78504-63-9 | Details |
| 2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid | C12H10N2O3 | 80047-38-7 | Details |
| Vortioxetine Impurity 22 | C38H44N4OS2 | 2476761-84-7 | Details |
| 4-ethoxy-3-(4-pyridyl)-3-buten-2-one | C11H13NO2 | 88349-61-5 | Details |
| Milrinone Impurity 15 | C12H9N3O2 | 156033-07-7 | Details |
| MILRINONE RELATED COMPOUND A (50 MG) (1,6-DIHYDRO-2-METHYL-6-OXO(3,4'-BIPYRIDINE)-5-CAR-BOXAMIDE) | C12H11N3O2 | 80047-24-1 | Details |
| Vortioxetine Impurity 26 | C18H22N2S | 2137588-68-0 | Details |
| Vortioxetine Impurity 1 | C17H20N2S | 1293489-71-0 | Details |
| 1-[2-[(2,6-diMethylphenyl)thio]phenyl]- Piperazine | C18H22N2S | 508233-76-9 | Details |
| Vortioxetine Impurity 4 | C18H22N2S | 1293489-77-6 | Details |
| 1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine | C18H22N2S | 1293489-74-3 | Details |
| Vortioxetine impurity S | C18H22N2S | 1815608-51-5 | Details |
| Vortioxetine Imp.E | C18H22N2S | 508233-77-0 | Details |
| 6-Aminouracil | C4H5N3O2 | 873-83-6 | Details |
| 2,4(1H,3H)-Pyrimidinedione, 6-amino-1,3-diethyl-5-nitro- | C8H12N4O4 | 146946-10-3 | Details |
| Vortioxetine Impurity 3 | C17H20N2S | 508233-82-7 | Details |
| Vortioxetine Impurity D | C18H22N2S | 508233-75-8 | Details |
| Istradefylline Impurity 10 | C6H8N4O3 | 1019659-02-9 | Details |
| 2,4(1H,3H)-Pyrimidinedione, 6-amino-3-ethyl- | C6H9N3O2 | 21237-00-3 | Details |
| Itraphylline impuritie7 | C18H20N4O4 | 155272-03-0 | Details |
| Celecoxib iMpurity-G | C15H17N3O2S | 1061214-06-9 | Details |
| Celecoxib Impurity 11 | C11H9F3N2 | 219986-64-8 | Details |
| Celecoxib Impurity 2 | C11H9F3N2 | 948293-46-7 | Details |
| 4,4,4-Trifluoro-1-phenyl-1,3-butanedione | C10H7F3O2 | 326-06-7 | Details |
| Celecoxib Impurity 30 | C11H9F3O2 | 53764-99-1 | Details |
| Methyl 2-fluoro-4-((1-methoxy-2-methyl-1-oxopropan-2-yl)amino)benzoate | C13H16FNO4 | 1802242-47-2 | Details |
| Enzalutamide Impurity 7 | C11H12FNO4 | 1332524-02-3 | Details |
| Enzalutamide Impurity I | C21H18F4N4O3S | 2030242-21-6 | Details |
| Acotiamide impurity 5 | C12H22N4OS | 206882-15-7 | Details |
| Acotiamide impurity C | C17H28N2O4 | 1824734-16-8 | Details |
| Elagolix Impurity 9 | C40H44F5N3O7 | 2316733-81-8 | Details |
| Vonoprazan Impurity 14 | C16H10FN3O2S | 1807642-39-2 | Details |
| Celebrex P | C17H13F3N2O3S | 921617-76-7 | Details |
| Celecoxib Carboxylic Acid | C17H12F3N3O4S | 170571-01-4 | Details |
| Finasteride Impurity 8 | C8H2Cl2N2O2 | 4640-41-9 | Details |
| N-Methyl OMeprazole (Mixture of isoMers with the Methylated nitrogens of iMidazole) | C18H21N3O3S | 89352-76-1 | Details |
| 3-[(4-AMino-2-Methyl-5-pyriMidinyl)Methyl]-4-Methyl-5-[2-(sulfooxy)ethyl]thiazoliuM Inner Salt | C12H16N4O4S2 | 2380-61-2 | Details |
| 1,3-Diazepane-2,4,6-trione | C5H6N2O3 | 338756-68-6 | Details |
| METHYL 4-METHYLCINNAMATE | C11H12O2 | 20754-20-5 | Details |
| Ozagrel Impurity 38 | C12H14O2 | 24393-49-5 | Details |
| Ozagrel Impurity 38 | C12H14O2 | 20511-20-0 | Details |
| Vonoprazan Impurity X Fumaric acid | C21H21N3O6S | 928325-82-0 | Details |
| Vonoprazan Impurity U9 | C18H18FN3O2S | 1885094-62-1 | Details |
| 4-Methylcinnamic acid | C10H10O2 | 1866-39-3 | Details |
| Ozagrel Impurity 37 | C12H14O3 | 530145-11-0 | Details |
| 1-[2-[(2,4-diMethylphenyl)sulfinyl]phenyl]- Piperazine | C18H22N2OS | 1429908-35-9 | Details |
| Vortioxetine Impurity 2 | C17H20N2S | 1293489-69-6 | Details |
| Febuxostat Impurity 27 | C21H15N3O3 | 7753-13-1 | Details |
| 4-HYDROXYTHIOBENZAMIDE | C7H7NOS | 25984-63-8 | Details |
| Febuxostat Impurity 61 | C9H10O2S | 168780-80-1 | Details |
| Febuxostat Impurity 9 | C16H16N2O3S | 1657014-33-9 | Details |
| Febuxostat Impurity 64 | C20H24N2O3S | 923942-36-3 | Details |
| Febuxostat Impurity 17 | C15H14N2O3S | 1530308-87-2 | Details |
| Febuxostat Impurity 7 | C16H18N2O4S | 1350352-70-3 | Details |
| FeBuxostat Impurity 18 | C12H9NO4S | 1312815-35-2 | Details |
| Febuxostat Impurity 70 | C16H16N2O3S | 2418591-43-0 | Details |
| Enzalutamide Impurity O | C21H17F3N4O2S | 915087-16-0 | Details |
| N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine methyl ester | C13H17FN2O3 | 1332524-01-2 | Details |
| Methyl5-chloro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate | C6H5ClN2O4 | 91447-90-4 | Details |
| Ozagrel Impurity 38 | C12H14O2 | 97585-04-1 | Details |
| Benzenesulfonamide, 4-[2-(1-phenylethylidene)hydrazinyl]- | C14H15N3O2S | 1135952-91-8 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 | ||||